[Kyowa Hakko Kogyo]

1949	Establishment of Kyowa Hakko Kogyo
1951	Introduced production technology of Streptomycin, an anti-tubercular drug from US pharmaceutical company Merck & Co.,Inc.and succeeded in its mass production
1956	Success of isolation and commercially mass-production of the anticanser drug,MitomycinC. Invention of the process of L-Glutamic acid production by fermentation(a world first) Pioneered the major business industry of amino-acid fermentation.
1958	Invention of the process of L-Lysin production by fermentation. Release of a plant growth regulator,Gibberellin Kyowa(Contribution to production of seedless grapes)
1969	Establishment of Kyowa Hakko USA
1973	Establishment of Kyowa Hakko Europe
1981	Establishment of the Bio Business Headquarters
2005	Completion of the transition to an operating holding company(Phamaceuticals and Bio-chemicals are its main pillars)
2007	Announced a strategic alliance between Kyowa Hakko Group and Kirin Group.

[Kyowa Hakko Bio]

2008	Establishment of Kyowa Hakko Bio (succeed Bio-Chemical business from Kyowa Hakko Kogyo)